NAD+ telehealth cost: what providers charge and how to evaluate a quote
NAD+ is a coenzyme present in every living cell, central to mitochondrial energy production and to the activity of sirtuins and PARP enzymes involved in DNA repair. It is sold by longevity and wellness clinics as an intravenous infusion, a subcutaneous injection and an oral or sublingual supplement, marketed for energy, cognition, addiction recovery and anti-ageing.
What telehealth providers charge
Publishing an unverified number would be worse than publishing none. When we have captured them, they will appear here with a source and a verification date, exactly like our GLP-1 pricing.
Normalise any quote before you compare it
Because we will not hand you a number we cannot stand behind, the useful thing we can give you is the method — the same one we apply to GLP-1 pricing, where we do hold verified figures.
| Ask for… | Because… |
|---|---|
| The total monthly cost, every fee included | Split billing — medication plus a membership — is the commonest way a price looks lower than it is |
| The ongoing price, not the first month | Introductory rates are customer-acquisition pricing. You pay the ongoing rate eleven months of twelve |
| Whether the price rises with dose | A programme cheapest at the starting dose can be the most expensive at maintenance |
| What happens if you cancel early | On a committed plan this is the question most likely to cost you money |
| Whether labs and shipping are included | 'All-inclusive' is used loosely. Test it against specifics |
| The annual total | Monthly figures are how this is marketed; annual totals are how it is lived |
Frequently asked questions
What does NAD+ cost through telehealth?
We have not verified a market price. On October 15, 2026, Oak Longevity listed NAD+ injections at $175 a month, regularly $199, a promotional price. That is one provider’s page, not a typical price. Ask any clinic for the total cost per month, including visits and supplies, in writing.
Is NAD+ FDA-approved?
No. There is no FDA-approved NAD+ drug as of October 15, 2026. NAD is in Category 1 of FDA’s interim 503A policy, so licensed pharmacies may compound it while FDA evaluates it. That is enforcement discretion, not approval or proof that it works.
Does NAD+ work?
Human studies of NAD+ injections and drips are small and short and mostly show that NAD+ levels rise. Claims about slower ageing, energy or sharper thinking rest largely on animal research. We have not re-read the literature for this update and cite no trial.
Sources
- U.S. Food and Drug Administration — approved labels and compounding guidance for this molecule.
- PubMed / NIH — indexed human clinical literature.
- ClinicalTrials.gov — registered trials, where they exist.
- Our source hierarchy and pricing-verification methodology.